Letter Regarding "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib".

导出 LinkOut

翻译打印收藏纠错

作者： Sophie M,Ernst ^[1] ; Jan H,von der Thüsen ^[2] ; Hendrikus J,Dubbink ^[2] ; Anne-Marie C,Dingemans ^[3]

作者单位： Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. ^[1] Department of Pathology and Clinical Bioinformatics, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. ^[2] Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Electronic address: a.dingemans@erasmusmc.nl. ^[3]

主题词人类(Humans);肺肿瘤(Lung Neoplasms);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);突变(Mutation);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras))

DOI 10.1016/j.jtho.2024.06.014

PMID 39112013

发布时间 2024-08-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交